[Hepatic Insulin Resistance and Type 2 Diabetes Mellitus]

Fu-Jun Liu1, Li-Li Chang1, Wei-Lan Wang1

  • 1Xinjiang Key Laboratory of Biological Resources and Genetic Engineering,College of Life Science and Technology, Xinjiang University,Urumqi 830046,China.

Insights

Insulin resistance (IR), a key feature of type 2 diabetes, involves impaired glucose and lipid metabolism. Understanding its molecular mechanisms, including oxidative stress and inflammation, offers new therapeutic targets for diabetes treatment.

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Biology
  • Pathophysiology

Background:

  • Insulin resistance (IR) is characterized by hyperinsulinemia and impaired glucose tolerance due to reduced insulin sensitivity in tissues like the liver.
  • IR is a central pathological feature of type 2 diabetes mellitus (T2DM).
  • Research into anti-diabetes strategies heavily focuses on understanding the pathogenesis of IR.

Purpose of the Study:

  • To review the molecular mechanisms underlying insulin resistance in type 2 diabetes.
  • To explore the roles of glucose and lipid metabolism, oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, and inflammation in hepatic IR.
  • To provide theoretical guidance for novel diabetes mellitus treatments.

Main Methods:

  • Literature review of molecular mechanisms.
  • Analysis of pathways involved in glucose and lipid metabolism.
  • Examination of cellular stress responses (oxidative, mitochondrial, ER) and inflammation.

Main Results:

  • IR involves complex molecular pathways affecting glucose and lipid homeostasis.
  • Oxidative stress, mitochondrial dysfunction, ER stress, and inflammation are critical contributors to hepatic IR in T2DM.
  • These interconnected mechanisms highlight the multifaceted nature of insulin resistance.

Conclusions:

  • A comprehensive understanding of these molecular mechanisms is crucial for developing effective treatments for T2DM.
  • Targeting pathways related to metabolism, stress, and inflammation may offer new therapeutic avenues.
  • This review provides insights for future research and clinical strategies in managing diabetes mellitus.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
664
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
272